Are You Looking for a Top Momentum Pick? Why AbCellera Biologics Inc. (ABCL) is a Great ChoiceZacks Investment Research • 07/07/26
Is ABCELLERA BIOLG (ABCL) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 07/03/26
ABCELLERA BIOLG (ABCL) Surges 7.1%: Is This an Indication of Further Gains?Zacks Investment Research • 06/25/26
JAZZ & ABCL Team Up to Develop Next-Generation Solid Tumor TherapiesZacks Investment Research • 06/18/26
Is ABCELLERA BIOLG (ABCL) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 06/17/26
Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific AntibodiesBusiness Wire • 06/17/26
Wall Street Analysts Think ABCELLERA BIOLG (ABCL) Could Surge 85.59%: Read This Before Placing a BetZacks Investment Research • 06/08/26
AbCellera Biologics Inc. (ABCL) Presents at Jefferies Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/05/26
Has ABCELLERA BIOLG (ABCL) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 06/01/26
After Golden Cross, AbCellera Biologics Inc. (ABCL)'s Technical Outlook is BrightZacks Investment Research • 05/29/26
Wall Street Analysts Believe ABCELLERA BIOLG (ABCL) Could Rally 97.28%: Here's is How to TradeZacks Investment Research • 05/22/26
AbCellera Biologics Inc. (ABCL) Presents at Bank of America Global Healthcare Conference 2026 TranscriptSeeking Alpha • 05/14/26
AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Beats Revenue EstimatesZacks Investment Research • 05/11/26
AbCellera Reports Q1 2026 Business Results & Announces Positive Interim Phase 1 Clinical Data for ABCL635Business Wire • 05/11/26